Fort Sheridan Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Sell
15,474
-2,482
-14% -$135K 0.07% 157
2026
Q1
$1.13M Buy
17,956
+544
+3% +$43.5K 0.14% 109
2025
Q4
$1.66M Sell
17,412
-23
-0.1% -$2.25K 0.21% 83
2025
Q3
$1.7M Buy
17,435
+18
+0.1% +$1.86K 0.22% 80
2025
Q2
$1.87M Sell
17,417
-7
-0% -$708 0.27% 69
2025
Q1
$1.76M Sell
17,424
-455
-3% -$45.8K 0.27% 68
2024
Q4
$1.6M Buy
17,879
+240
+1% +$21.1K 0.23% 76
2024
Q3
$1.48M Buy
17,639
+410
+2% +$32.3K 0.22% 76
2024
Q2
$1.33M Buy
17,229
+3,786
+28% +$277K 0.21% 79
2024
Q1
$921K Buy
13,443
+1,805
+16% +$116K 0.17% 87
2023
Q4
$673K Sell
11,638
-3
-0% -$160 0.13% 103
2023
Q3
$615K Buy
11,641
+2,530
+28% +$133K 0.14% 104
2023
Q2
$493K Buy
9,111
+724
+9% +$37.8K 0.11% 121
2023
Q1
$420K Buy
8,387
+148
+2% +$6.97K 0.11% 126
2022
Q4
$381K Hold
8,239
0.12% 122
2022
Q3
$319K Hold
8,239
0.11% 129
2022
Q2
$307K Hold
8,239
0.1% 133
2022
Q1
$365K Hold
8,239
0.11% 125
2021
Q4
$350K Sell
8,239
-4
-0% -$168 0.1% 135
2021
Q3
$358K Buy
+8,243
New +$365K 0.12% 128

Other funds holding BSX

Fort Sheridan Advisors's BSX Position: Q2 2026 in Review

Fort Sheridan Advisors reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $135K and leaving 15,474 shares worth $660K. The position accounts for 0.07% of the portfolio, ranked #157.

Fort Sheridan Advisors first reported a position in BSX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.87M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fort Sheridan Advisors held 15,474 shares of Boston Scientific worth $660K as of Q2 2026.
  • Fort Sheridan Advisors sold 2,482 Boston Scientific shares in Q2 2026, an estimated $135K.
  • Boston Scientific made up 0.07% of Fort Sheridan Advisors's portfolio in Q2 2026, its #157 holding.
  • Fort Sheridan Advisors first reported a position in Boston Scientific in Q3 2021 and has held it in 20 quarters since.
  • Fort Sheridan Advisors's Boston Scientific position peaked at $1.87M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.